As a member of Cannabis Stock Trades, you'll have total and transparent access to a professionally managed model cannabis portfolio.
Most people don't have the time to thoroughly research cannabis stocks, nor the experience to know when to buy or sell.
Cash in on this incredible opportunity with the guidance of a professional advisor and leading cannabis stock expert.
Leading The Way
Michael Vodicka is a licensed investment advisor, founder of a million-dollar wealth management firm and a globally syndicated financial journalist. He, and his wealth management clients, have been profiting from cannabis stocks since 2013.
Now Mr. Vodicka brings this experience and guidance to the members of Cannabis Stock Trades.
The cannabis sector is loaded with promising young biotechs. One one hand that’s great. Investors have a lot of options to choose from. But on the other hand, it presents a new challenge. The cannabis biotech industry is super competitive, and only the best companies will successfully navigate the FDA gauntlet and release profitable drugs.
Today – I want to share one of the most promising young cannabis biotechs.
This company’s lead drug candidate is making major progress through clinical trials.
Canadian legislators just delivered another big win for cannabis investors.
On November 28, members of parliament (MP) overwhelmingly voted in favor of C-45, the bill is set to legalize recreational cannabis in the summer of 2018. The bill will now head to the Senate where it is expected to run into some resistance but ultimately pass.